Skip to main content

Table 1 Number of eyes reaching the follow-up in the ranibizumab and aflibercept treated groups

From: The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration

 

Ranibizumab

Aflibercept

Time point

n (eyes)

n (eyes)

Baseline

184

52

at 6 months

184

52

at 12 months

161

28

at 18 months

103

0

at 24 months

51

0

  1. Table legend: The column with “n” corresponds to the number of eyes reaching the follow-up
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us